Clorox (NYSE:CLX) Price Target Cut to $145.00 by Analysts at Deutsche Bank

Clorox (NYSE:CLX) had its target price cut by Deutsche Bank from $151.00 to $145.00 in a report published on Thursday, AnalystRatings.com reports. They currently have a hold rating on the stock.

A number of other equities research analysts also recently issued reports on CLX. Morgan Stanley reissued an underweight rating and set a $134.00 price target (down previously from $144.00) on shares of Clorox in a research report on Monday. Credit Suisse Group lowered their price target on Clorox from $172.00 to $168.00 and set an outperform rating for the company in a research report on Thursday. Barclays downgraded Clorox from an equal weight rating to an underweight rating and lowered their price target for the company from $142.00 to $141.00 in a research report on Monday, September 23rd. UBS Group boosted their price target on Clorox from $110.00 to $128.00 and gave the company a sell rating in a research report on Friday, August 2nd. Finally, Zacks Investment Research raised Clorox from a sell rating to a hold rating and set a $175.00 price target for the company in a research report on Monday, July 29th. Four research analysts have rated the stock with a sell rating, eight have assigned a hold rating and two have issued a buy rating to the stock. The stock has an average rating of Hold and a consensus target price of $152.25.

CLX stock traded up $4.36 during trading on Thursday, reaching $151.38. 1,224,349 shares of the stock traded hands, compared to its average volume of 1,024,022. The business’s 50 day moving average price is $156.52 and its 200-day moving average price is $155.59. Clorox has a 52-week low of $141.53 and a 52-week high of $167.70. The company has a debt-to-equity ratio of 4.09, a current ratio of 0.91 and a quick ratio of 0.55. The firm has a market capitalization of $19.02 billion, a PE ratio of 23.95, a P/E/G ratio of 5.04 and a beta of 0.40.

Clorox (NYSE:CLX) last posted its quarterly earnings results on Thursday, August 1st. The company reported $1.88 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.84 by $0.04. Clorox had a return on equity of 118.88% and a net margin of 13.20%. The firm had revenue of $1.63 billion during the quarter, compared to the consensus estimate of $1.69 billion. During the same quarter in the previous year, the business earned $1.66 earnings per share. The firm’s quarterly revenue was down 3.8% compared to the same quarter last year. On average, equities research analysts predict that Clorox will post 6.38 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Wednesday, October 30th will be paid a $1.06 dividend. This represents a $4.24 annualized dividend and a dividend yield of 2.80%. The ex-dividend date of this dividend is Tuesday, October 29th. Clorox’s dividend payout ratio (DPR) is 67.09%.

In related news, SVP Diego J. Barral sold 1,987 shares of the business’s stock in a transaction dated Friday, August 2nd. The stock was sold at an average price of $157.59, for a total value of $313,131.33. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, SVP Michael R. Costello sold 6,997 shares of the business’s stock in a transaction dated Wednesday, September 4th. The stock was sold at an average price of $162.56, for a total value of $1,137,432.32. Following the completion of the transaction, the senior vice president now owns 29,016 shares in the company, valued at approximately $4,716,840.96. The disclosure for this sale can be found here. In the last quarter, insiders sold 15,609 shares of company stock worth $2,497,443. Insiders own 1.40% of the company’s stock.

Large investors have recently added to or reduced their stakes in the stock. Zions Bancorporation N.A. acquired a new position in shares of Clorox in the first quarter worth about $28,000. Northstar Capital Management LLC acquired a new stake in Clorox during the first quarter valued at approximately $29,000. Heritage Wealth Advisors acquired a new stake in Clorox during the second quarter valued at approximately $30,000. Transamerica Financial Advisors Inc. acquired a new stake in Clorox during the second quarter valued at approximately $41,000. Finally, Mirova acquired a new stake in Clorox during the second quarter valued at approximately $47,000. Institutional investors and hedge funds own 78.21% of the company’s stock.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.

Read More: What is a Market Correction?

Analyst Recommendations for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.